{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:41:19Z","timestamp":1794271279132,"version":"4.9.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Acute myeloid leukemia (AML) is an aggressive hematologic malignancy where chemoresistance, particularly to daunorubicin (DNR), frequently leads to treatment failure and relapse. Current resistance prediction methods are often slow and inaccessible in clinical settings, delaying crucial treatment adjustments. There is an urgent need for rapid, reliable, and clinically accessible diagnostic tools to identify DNR resistance early, enabling personalized therapeutic strategies and improving patient outcomes. To address this problem, we developed a rapid flow cytometric assay to detect reduced intracellular DNR accumulation, a marker of drug resistance. This was complemented by FTIR spectroscopy, confocal microscopy, and proteomic profiling to validate findings and explore underlying mechanisms in drug-resistant and sensitive cells. The flow cytometry method demonstrated that the novel Sensitivity Index (S-index) accurately predicts DNR resistance after short drug exposure and correlates strongly with IC\n                    <jats:sub>50<\/jats:sub>\n                    values. Complementary FTIR and confocal microscopy revealed distinct biochemical and structural differences between resistant and sensitive cells. Proteomic analysis suggests that increased drug metabolism contributes to DNR resistance, supporting the flow cytometry data. In summary, our findings demonstrate that flow cytometry provides a reliable and clinically accessible tool for targeted diagnostics, crucial for optimizing patient-specific treatment strategies based on rapid assessment of daunorubicin resistance in AML.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-30844-2","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T01:34:28Z","timestamp":1765244068000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Flow cytometry-based targeted diagnostics for rapid assessment of daunorubicin resistance in acute myeloid leukemia"],"prefix":"10.1038","volume":"16","author":[{"given":"Aleksandra","family":"Kaczorowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemys\u0142aw","family":"Sare\u0142o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlena","family":"G\u0105sior-G\u0142ogowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Zio\u0142o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Karpi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"\u0141aczma\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Sobas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Wr\u00f3bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halina","family":"Podbielska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Kopaczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Ka\u0142as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"30844_CR1","doi-asserted-by":"publisher","unstructured":"Ferrara, F. & Schiffer, C. A. \u2018Acute myeloid leukaemia in adults\u2019, The Lancet 3819865, 484\u2013495. https:\/\/doi.org\/10.1016\/S0140-6736(12)61727-9 (2013).","DOI":"10.1016\/S0140-6736(12)61727-9"},{"issue":"4","key":"30844_CR2","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H. D\u00f6hner","year":"2017","unstructured":"D\u00f6hner, H. et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 129(4), 424\u2013447. https:\/\/doi.org\/10.1182\/blood-2016-08-733196 (2017).","journal-title":"Blood"},{"issue":"23","key":"30844_CR3","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E. Papaemmanuil","year":"2016","unstructured":"Papaemmanuil, E. et al. Genomic classification and prognosis in acute myeloid leukemia. N. Engl. J. Med. 374(23), 2209\u20132221. https:\/\/doi.org\/10.1056\/NEJMoa1516192 (2016).","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"30844_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/leu.2014.242","volume":"29","author":"R. B. Walter","year":"2015","unstructured":"Walter, R. B. et al. Resistance prediction in AML: Analysis of 4601 patients from MRC\/NCRI, HOVON\/SAKK, SWOG and MD Anderson Cancer Center. Leukemia 29(2), 312\u2013320. https:\/\/doi.org\/10.1038\/leu.2014.242 (2015).","journal-title":"Leukemia"},{"key":"30844_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lrr.2016.06.001","volume":"6","author":"AM Almeida","year":"2016","unstructured":"Almeida, A. M. & Ramos, F. Acute myeloid leukemia in the older adults. Leuk. Res. Rep. 6, 1\u20137. https:\/\/doi.org\/10.1016\/j.lrr.2016.06.001 (2016).","journal-title":"Leuk. Res. Rep."},{"key":"30844_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2012.02.001","volume":"15","author":"B. C. Shaffer","year":"2012","unstructured":"Shaffer, B. C. et al. Drug resistance: Still a daunting challenge to the successful treatment of AML. Drug Resist. Updates. 15, 1\u20132. https:\/\/doi.org\/10.1016\/j.drup.2012.02.001 (2012).","journal-title":"Drug Resist. Updates"},{"key":"30844_CR7","doi-asserted-by":"publisher","first-page":"100805","DOI":"10.1016\/j.drup.2022.100805","volume":"61","author":"K. \u0160imoni\u010dov\u00e1","year":"2022","unstructured":"\u0160imoni\u010dov\u00e1, K. et al. Different mechanisms of drug resistance to hypomethylating agents in the treatment of myelodysplastic syndromes and acute myeloid leukemia. Drug Resist. Updates. 61, 100805. https:\/\/doi.org\/10.1016\/j.drup.2022.100805 (2022).","journal-title":"Drug Resist. Updates"},{"key":"30844_CR8","doi-asserted-by":"publisher","unstructured":"Tafuri, A. et al. Prognostic value of rhodamine-efflux and MDR-1\/P-170 expression in childhood acute leukemia. Leuk. Res. 19(12), 927\u2013931. https:\/\/doi.org\/10.1016\/0145-2126(95)00092-5 (1995).","DOI":"10.1016\/0145-2126(95)00092-5"},{"key":"30844_CR9","doi-asserted-by":"publisher","unstructured":"Boer, R., Haas, S. & Sch\u00f6dl, A. Influence of dexniguldipine-HCl on rhodamine-123 accumulation in a multidrug-resistant leukaemia cell line: Comparison with other chemosensitisers. Eur. J. Cancer. 30(8), 1117\u20131123. https:\/\/doi.org\/10.1016\/0959-8049(94)90469-3 (1994).","DOI":"10.1016\/0959-8049(94)90469-3"},{"issue":"2","key":"30844_CR10","doi-asserted-by":"publisher","first-page":"FSO190","DOI":"10.4155\/fsoa-2017-0003","volume":"3","author":"T. G. van Meijer","year":"2017","unstructured":"Meijer, T. G., Naipal, K. A., Jager, A. & van Gent, D. C. Ex vivo tumor culture systems for functional drug testing and therapy response prediction. Future Sci. OA. 3(2), 190. https:\/\/doi.org\/10.4155\/fsoa-2017-0003 (2017).","journal-title":"Future Sci. OA"},{"issue":"1","key":"30844_CR11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13048-017-0365-9","volume":"10","author":"F. C. Kischkel","year":"2017","unstructured":"Kischkel, F. C. et al. Prediction of clinical response to drugs in ovarian cancer using the chemotherapy resistance test (CTR-test). J. Ovarian Res. 10(1), 72. https:\/\/doi.org\/10.1186\/s13048-017-0365-9 (2017).","journal-title":"J. Ovarian Res."},{"issue":"4","key":"30844_CR12","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.3892\/ol.2017.5725","volume":"13","author":"M. Rogali\u0144ska","year":"2017","unstructured":"Rogali\u0144ska, M. et al. Personalized therapy tests for the monitoring of chronic lymphocytic leukemia development. Oncol. Lett. 13(4), 2079\u20132084. https:\/\/doi.org\/10.3892\/ol.2017.5725 (2017).","journal-title":"Oncol. Lett."},{"issue":"3","key":"30844_CR13","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3892\/ijo.2015.2823","volume":"46","author":"M. Rogali\u0144ska","year":"2015","unstructured":"Rogali\u0144ska, M. et al. Relationship between in vitro drug sensitivity and clinical response of patients to treatment in chronic lymphocytic leukemia. Int. J. Oncol. 46(3), 1259\u20131267. https:\/\/doi.org\/10.3892\/ijo.2015.2823 (2015).","journal-title":"Int. J. Oncol."},{"key":"30844_CR14","doi-asserted-by":"publisher","unstructured":"Blom, K., Nygren, P., Larsson, R. & Andersson, C. R. Predictive Value of ex vivo chemosensitivity assays for individualized cancer chemotherapy: A meta-analysis. SLAS Technol. 22(3), 306\u2013314. https:\/\/doi.org\/10.1177\/2472630316686297 (2017).","DOI":"10.1177\/2472630316686297"},{"issue":"1","key":"30844_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/08982104.2016.1140184","volume":"27","author":"J. Chen","year":"2017","unstructured":"Chen, J. et al. Delivery of fluorescent-labeled cyclodextrin by liposomes: Role of transferrin modification and phosphatidylcholine composition. J. Liposome Res. 27(1), 21\u201331. https:\/\/doi.org\/10.3109\/08982104.2016.1140184 (2017).","journal-title":"J. Liposome Res."},{"issue":"2","key":"30844_CR16","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s10120-015-0506-z","volume":"19","author":"N. Tanigawa","year":"2016","unstructured":"Tanigawa, N. et al. Exploratory phase II trial in a multicenter setting to evaluate the clinical value of a chemosensitivity test in patients with gastric cancer (JACCRO-GC 04, Kubota memorial trial). Gastric Cancer. 19(2), 350\u2013360. https:\/\/doi.org\/10.1007\/s10120-015-0506-z (2016).","journal-title":"Gastric Cancer"},{"issue":"4","key":"30844_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.clml.2013.11.006","volume":"14","author":"T. A. Bennett","year":"2014","unstructured":"Bennett, T. A. et al. Pharmacological profiles of acute myeloid leukemia treatments in patient samples by automated flow cytometry: A Bridge to individualized medicine. Clin. Lymphoma Myeloma Leuk. 14(4), 305\u2013318. https:\/\/doi.org\/10.1016\/j.clml.2013.11.006 (2014).","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"2","key":"30844_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/BF02686104","volume":"35","author":"R. D. Blumenthal","year":"2007","unstructured":"Blumenthal, R. D. & Goldenberg, D. M. Methods and goals for the use of in vitro and in vivo chemosensitivity testing. Mol. Biotechnol. 35(2), 185\u2013197. https:\/\/doi.org\/10.1007\/BF02686104 (2007).","journal-title":"Mol. Biotechnol."},{"issue":"11","key":"30844_CR19","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.3390\/cells9112527","volume":"9","author":"I. Demers","year":"2020","unstructured":"Demers, I., Donkers, J., Kremer, B. & Speel, E. J. Ex vivo culture models to indicate therapy response in head and neck squamous cell carcinoma. Cells 9(11), 2527. https:\/\/doi.org\/10.3390\/cells9112527 (2020).","journal-title":"Cells"},{"key":"30844_CR20","doi-asserted-by":"publisher","first-page":"100730","DOI":"10.1016\/j.drup.2020.100730","volume":"53","author":"D. G. J. Cucchi","year":"2020","unstructured":"Cucchi, D. G. J., Groen, R. W. J., Janssen, J. J. W. M. & Cloos, J. Ex vivo cultures and drug testing of primary acute myeloid leukemia samples: current techniques and implications for experimental design and outcome. Drug Resist. Updates 53, 100730. https:\/\/doi.org\/10.1016\/j.drup.2020.100730 (2020).","journal-title":"Drug Resist. Updates"},{"issue":"6","key":"30844_CR21","doi-asserted-by":"publisher","first-page":"721","DOI":"10.6004\/jnccn.2019.0028","volume":"17","author":"M. S. Tallman","year":"2019","unstructured":"Tallman, M. S. et al. Acute myeloid leukemia, version 3.2019, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Canc. Netw. 17(6), 721\u2013749. https:\/\/doi.org\/10.6004\/jnccn.2019.0028 (2019).","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"13","key":"30844_CR22","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1056\/NEJMoa0901409","volume":"361","author":"B. L\u00f6wenberg","year":"2009","unstructured":"L\u00f6wenberg, B. et al. High-dose daunorubicin in older patients with acute myeloid leukemia. N. Engl. J. Med. 361(13), 1235\u20131248. https:\/\/doi.org\/10.1056\/NEJMoa0901409 (2009).","journal-title":"N. Engl. J. Med."},{"key":"30844_CR23","doi-asserted-by":"publisher","unstructured":"Meredith, A. M. & Dass, C. R. Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism. J. Pharm. Pharmacol. 68, 729\u2013741. https:\/\/doi.org\/10.1111\/jphp.12539 (2016).","DOI":"10.1111\/jphp.12539"},{"issue":"2","key":"30844_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1124\/pr.56.2.6","volume":"56","author":"G. Minotti","year":"2004","unstructured":"Minotti, G., Menna, P., Salvatorelli, E., Cairo, G. & Gianni, L. Anthracyclines: Molecular advances and Pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol. Rev. 56(2), 185\u2013229. https:\/\/doi.org\/10.1124\/pr.56.2.6 (2004).","journal-title":"Pharmacol. Rev."},{"key":"30844_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.semcdb.2019.05.006","volume":"98","author":"T. Capel\u00f4a","year":"2020","unstructured":"Capel\u00f4a, T., Benyahia, Z., Zampieri, L. X., Blackman, M. C. N. M. & Sonveaux, P. Metabolic and non-metabolic pathways that control cancer resistance to anthracyclines. Semin Cell. Dev. Biol. 98, 181\u2013191. https:\/\/doi.org\/10.1016\/j.semcdb.2019.05.006 (2020).","journal-title":"Semin Cell. Dev. Biol."},{"issue":"2","key":"30844_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/cyto.990180203","volume":"18","author":"D. Campana","year":"1994","unstructured":"Campana, D. Applications of cytometry to study acute leukemia: In vitro determination of drug sensitivity and detection of minimal residual disease. Cytometry 18(2), 68\u201374. https:\/\/doi.org\/10.1002\/cyto.990180203 (1994).","journal-title":"Cytometry"},{"key":"30844_CR27","doi-asserted-by":"publisher","first-page":"1610659","DOI":"10.3389\/pore.2022.1610659","volume":"28","author":"F. Tak\u00e1cs","year":"2022","unstructured":"Tak\u00e1cs, F. et al. Revealing a phenotypical appearance of ibrutinib resistance in patients with chronic lymphocytic leukaemia by flow cytometry. Pathol. Oncol. Res. 28, 1610659. https:\/\/doi.org\/10.3389\/pore.2022.1610659 (2022).","journal-title":"Pathol. Oncol. Res."},{"issue":"5","key":"30844_CR28","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/JLB.5A0220-676RR","volume":"107","author":"L. Lin","year":"2020","unstructured":"Lin, L. et al. Ex-vivo drug testing predicts chemosensitivity in acute myeloid leukemia. J. Leukoc. Biol. 107(5), 859\u2013870. https:\/\/doi.org\/10.1002\/JLB.5A0220-676RR (2020).","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"30844_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/cryst15010020","volume":"15","author":"H. Sbirkova-Dimitrova","year":"2024","unstructured":"Sbirkova-Dimitrova, H., Rusew, R., Gerginov, H., Heroux, A. & Shivachev, B. L. Structural Characterization of B-DNA d(CGTGAATTCACG)2 in Complex with the Specific Minor Groove Binding Fluorescent Marker Hoechst 33342. Crystal (Basel). 15(1), 20. https:\/\/doi.org\/10.3390\/cryst15010020 (2024).","journal-title":"Crystal (Basel)"},{"issue":"22","key":"30844_CR30","doi-asserted-by":"publisher","first-page":"12032","DOI":"10.1073\/pnas.200221397","volume":"97","author":"X. Qu","year":"2000","unstructured":"Qu, X., Trent, J. O., Fokt, I., Priebe, W. & Chaires, J. B. Allosteric, chiral-selective drug binding to DNA. Proc. Natl. Acad. Sci. 97(22), 12032\u201312037. https:\/\/doi.org\/10.1073\/pnas.200221397 (2000).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"30844_CR31","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/cjoc.200990176","volume":"27","author":"R. Hajian","year":"2009","unstructured":"Hajian, R., Shams, N. & Parvin, A. DNA-binding studies of daunorubicin in the presence of methylene blue by spectroscopy and voltammetry techniques. Chin. J. Chem. 27(6), 1055\u20131060. https:\/\/doi.org\/10.1002\/cjoc.200990176 (2009).","journal-title":"Chin. J. Chem."},{"issue":"133","key":"30844_CR32","doi-asserted-by":"publisher","first-page":"20170408","DOI":"10.1098\/rsif.2017.0408","volume":"14","author":"A. C. Alves","year":"2017","unstructured":"Alves, A. C. et al. A biophysical approach to daunorubicin interaction with model membranes: Relevance for the drug\u2019s biological activity. J. R Soc. Interface. 14(133), 20170408. https:\/\/doi.org\/10.1098\/rsif.2017.0408 (2017).","journal-title":"J. R Soc. Interface"},{"key":"30844_CR33","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1007\/978-3-642-16712-6_55","volume-title":"Encyclopedia of Biophysics","author":"PF Cook","year":"2013","unstructured":"Cook, P. F. Steady-State enzyme kinetics. in Encyclopedia of Biophysics 2466\u20132470 (Springer Berlin Heidelberg, Berlin, Heidelberg, 2013). https:\/\/doi.org\/10.1007\/978-3-642-16712-6_55."},{"key":"30844_CR34","doi-asserted-by":"publisher","unstructured":"Lewis, R. N. A. H. & McElhaney, R. N. Fourier transform infrared spectroscopy in the study of lipid phase transitions in model and biological membranes 207\u2013226. (2007). https:\/\/doi.org\/10.1007\/978-1-59745-519-0_14.","DOI":"10.1007\/978-1-59745-519-0_14"},{"issue":"5","key":"30844_CR35","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3390\/membranes12050534","volume":"12","author":"M. C. Klaiss-Luna","year":"2022","unstructured":"Klaiss-Luna, M. C. & Manrique-Moreno, M. Infrared Spectroscopic study of multi-component lipid systems: A closer approximation to biological membrane fluidity. Membrane (Basel). 12(5), 534. https:\/\/doi.org\/10.3390\/membranes12050534 (2022).","journal-title":"Membrane (Basel)"},{"issue":"5","key":"30844_CR36","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/jbio.201000085","volume":"4","author":"J. G. Kelly","year":"2011","unstructured":"Kelly, J. G., Najand, G. M. & Martin, F. L. Characterisation of DNA methylation status using spectroscopy (mid-IR versus Raman) with multivariate analysis. J. Biophotonics. 4(5), 345\u2013354. https:\/\/doi.org\/10.1002\/jbio.201000085 (2011).","journal-title":"J. Biophotonics"},{"issue":"7","key":"30844_CR37","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1021\/ac1002728","volume":"82","author":"A. C. Leskovjan","year":"2010","unstructured":"Leskovjan, A. C., Kretlow, A. & Miller, L. M. Fourier Transform infrared imaging showing reduced unsaturated lipid content in the hippocampus of a mouse model of alzheimer\u2019s disease. Anal. Chem. 82(7), 2711\u20132716. https:\/\/doi.org\/10.1021\/ac1002728 (2010).","journal-title":"Anal. Chem."},{"key":"30844_CR38","doi-asserted-by":"publisher","unstructured":"Srour, B., Bruechert, S., Andrade, S. L. A. & Hellwig, P. Secondary structure determination by means of ATR-FTIR spectroscopy 195\u2013203. https:\/\/doi.org\/10.1007\/978-1-4939-7151-0_10 (2017).","DOI":"10.1007\/978-1-4939-7151-0_10"},{"issue":"1","key":"30844_CR39","doi-asserted-by":"publisher","first-page":"258758","DOI":"10.1155\/2013\/258758","volume":"2013","author":"A. Kaczmarek","year":"2013","unstructured":"Kaczmarek, A. et al. Radiation Sterilization of Anthracycline Antibiotics in Solid State. Sci. World J. 2013(1), 258758. https:\/\/doi.org\/10.1155\/2013\/258758 (2013).","journal-title":"Sci. World J."},{"issue":"1","key":"30844_CR40","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1504\/IJNBM.2009.027736","volume":"2","author":"G. A. R. Ahmed","year":"2009","unstructured":"Ahmed, G. A. R., Khorshid, F. A. R. & Kumosani, T. A. FT-IR spectroscopy as a tool for identification of apoptosis-induced structural changes in A549 cells treated with PM 701. Int. J. Nano Biomater. 2(1), 396\u2013408. https:\/\/doi.org\/10.1504\/IJNBM.2009.027736 (2009).","journal-title":"Int. J. Nano Biomater."},{"key":"30844_CR41","doi-asserted-by":"publisher","unstructured":"Sari\u0107, A., Raji\u0107, J., Toli\u0107, A., Du\u010di\u0107, T. & Vidakovi\u0107, M. Synchrotron-based FTIR microspectroscopy reveals DNA methylation profile in DNA-HALO structure. Spectrochim Acta Mol. Biomol. Spectrosc. 302, 123090. https:\/\/doi.org\/10.1016\/j.saa.2023.123090 (2023).","DOI":"10.1016\/j.saa.2023.123090"},{"key":"30844_CR42","doi-asserted-by":"publisher","unstructured":"Liu, K. Z., Jia, L., Kelsey, S. M., Newland, A. C. & Mantsch, H. H. \u2018Quantitative determination of apoptosis on leukemia cells by infrared spectroscopy\u2019, Apoptosis 6(4), 269\u2013278. https:\/\/doi.org\/10.1023\/A:1011383408381 (2001).","DOI":"10.1023\/A:1011383408381"},{"issue":"2","key":"30844_CR43","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1042\/bj20021021","volume":"369","author":"F. Gasparri","year":"2003","unstructured":"Gasparri, F. & Muzio, M. Monitoring of apoptosis of HL60 cells by Fourier-transform infrared spectroscopy. Biochem. J. 369(2), 239\u2013248. https:\/\/doi.org\/10.1042\/bj20021021 (2003).","journal-title":"Biochem. J."},{"issue":"7","key":"30844_CR44","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1016\/j.bpj.2009.07.026","volume":"97","author":"U. Zelig","year":"2009","unstructured":"Zelig, U., Kapelushnik, J., Moreh, R., Mordechai, S. & Nathan, I. Diagnosis of cell death by means of infrared spectroscopy. Biophys. J. 97(7), 2107\u20132114 . https:\/\/doi.org\/10.1016\/j.bpj.2009.07.026 (2009).","journal-title":"Biophys. J."},{"issue":"4","key":"30844_CR45","first-page":"6884","volume":"6","author":"UV Ushasree","year":"2017","unstructured":"Ushasree, U. V. & Adeel, A. A FTIR spectroscopic study on quantitation of glucose in human blood serum. Int. J. Innov. Res. Sci. Eng. Technol. 6(4), 6884\u20136890 (2017).","journal-title":"Int. J. Innov. Res. Sci. Eng. Technol."},{"key":"30844_CR46","doi-asserted-by":"publisher","unstructured":"Krishan, A. & Hamelik, R. M. \u2018Flow cytometric monitoring of fluorescent drug retention and efflux\u2019. in Chemosensitivity 149\u2013166 (Humana, New Jersey). https:\/\/doi.org\/10.1385\/1-59259-889-7:149.","DOI":"10.1385\/1-59259-889-7:149"},{"issue":"2","key":"30844_CR47","first-page":"237","volume":"22","author":"K. Wagner-Souza","year":"2008","unstructured":"Wagner-Souza, K. et al. Rhodamine 123 efflux in human subpopulations of hematopoietic stem cells: comparison between bone marrow, umbilical cord blood and mobilized peripheral blood CD34\u2009+\u2009cells. Int. J. Mol. Med. 22(2), 237\u2013242 (2008).","journal-title":"Int. J. Mol. Med."},{"issue":"16","key":"30844_CR48","doi-asserted-by":"publisher","first-page":"13802","DOI":"10.1021\/acs.jmedchem.4c00614","volume":"67","author":"M. A. van Gelder","year":"2024","unstructured":"van Gelder, M. A. et al. Novel N,N -Dimethyl-idarubicin analogues are effective cytotoxic agents for ABCB1-overexpressing, doxorubicin-resistant cells. J. Med. Chem. 67(16), 13802\u201313812. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c00614 (2024).","journal-title":"J. Med. Chem."},{"issue":"1","key":"30844_CR49","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/(SICI)1097-0320(19990215)38:1<24::AID-CYTO4>3.0.CO;2-7","volume":"38","author":"J. A. P\u00e9rez-Sim\u00f3n","year":"1999","unstructured":"P\u00e9rez-Sim\u00f3n, J. A. et al. Correlation of rhodamine 123 efflux by neoplastic plasma cells with clinical and biological characteristics of multiple myeloma. Cytometry 38(1), 24\u201329 (1999).","journal-title":"Cytometry"},{"key":"30844_CR50","doi-asserted-by":"publisher","first-page":"121926","DOI":"10.1016\/j.saa.2022.121926","volume":"286","author":"A. Pielesz","year":"2023","unstructured":"Pielesz, A., Binia\u015b, D., Waksma\u0144ska, W. & Bobi\u0144ski, R. Lipid bands of approx. 1740 cm\u20131 as spectral biomarkers and image of tissue oxidative stress. Spectrochim Acta Mol. Biomol. Spectrosc. 286, 121926. https:\/\/doi.org\/10.1016\/j.saa.2022.121926 (2023).","journal-title":"Spectrochim Acta Mol. Biomol. Spectrosc."},{"key":"30844_CR51","doi-asserted-by":"publisher","unstructured":"Guti\u00e9rrez, P. L., Gee, M. V. & Bachur, N. R. Kinetics of anthracycline antibiotic free radical formation and reductive glycosidase activity. Arch. Biochem. Biophys. 223(1), 68\u201375. https:\/\/doi.org\/10.1016\/0003-9861(83)90572-6 (1983).","DOI":"10.1016\/0003-9861(83)90572-6"},{"issue":"4","key":"30844_CR52","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.neo.2021.02.003","volume":"23","author":"D. Papadopoli","year":"2021","unstructured":"Papadopoli, D. et al. Perturbations of cancer cell metabolism by the antidiabetic drug canagliflozin. Neoplasia 23(4), 391\u2013399 (2021). https:\/\/doi.org\/10.1016\/j.neo.2021.02.003","journal-title":"Neoplasia"},{"key":"30844_CR53","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2024.127","author":"Y. Wang","year":"2024","unstructured":"Wang, Y., Yu, G. & Chen, X. Mechanism of ferroptosis resistance in cancer cells. Cancer Drug Resist. https:\/\/doi.org\/10.20517\/cdr.2024.127 (2024).","journal-title":"Cancer Drug Resist."},{"key":"30844_CR54","doi-asserted-by":"publisher","unstructured":"Tang, D. & Kang, R. NFE2L2 and ferroptosis resistance in cancer therapy (Cancer Drug Resistance, 2024). https:\/\/doi.org\/10.20517\/cdr.2024.123.","DOI":"10.20517\/cdr.2024.123"},{"issue":"2","key":"30844_CR55","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s43018-019-0018-6","volume":"1","author":"S. M. Corsello","year":"2020","unstructured":"Corsello, S. M. et al. Discovering the anticancer potential of non-oncology drugs by systematic viability profiling. Nat. Cancer. 1(2), 235\u2013248. https:\/\/doi.org\/10.1038\/s43018-019-0018-6 (2020).","journal-title":"Nat. Cancer"},{"issue":"7","key":"30844_CR56","doi-asserted-by":"publisher","first-page":"e9757","DOI":"10.15252\/msb.20209757","volume":"16","author":"F. Vazquez","year":"2020","unstructured":"Vazquez, F. & Boehm, J. S. The cancer dependency map enables drug mechanism-of\u2010action investigations. Mol. Syst. Biol. 16(7), e9757. https:\/\/doi.org\/10.15252\/msb.20209757 (2020).","journal-title":"Mol. Syst. Biol."},{"issue":"2","key":"30844_CR57","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2019.12.023","volume":"180","author":"D. P. Nusinow","year":"2020","unstructured":"Nusinow, D. P. et al. Quantitative proteomics of the cancer cell line encyclopedia. Cell 180(2), 387\u2013402e16. https:\/\/doi.org\/10.1016\/j.cell.2019.12.023 (2020).","journal-title":"Cell"},{"issue":"6","key":"30844_CR58","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/bioinformatics\/17.6.520","volume":"17","author":"O. Troyanskaya","year":"2001","unstructured":"Troyanskaya, O. et al. Missing value estimation methods for DNA microarrays. Bioinformatics 17(6), 520\u2013525. https:\/\/doi.org\/10.1093\/bioinformatics\/17.6.520 (2001).","journal-title":"Bioinformatics"},{"key":"30844_CR59","doi-asserted-by":"publisher","first-page":"W199","DOI":"10.1093\/nar\/gkz401","volume":"47","author":"Y. Liao","year":"2019","unstructured":"Liao, Y., Wang, J., Jaehnig, E. J., Shi, Z. & Zhang, B. WebGestalt 2019: gene set analysis toolkit with revamped UIs and apis. Nucleic Acids Res. 47, W199\u2013W205. https:\/\/doi.org\/10.1093\/nar\/gkz401 (2019).","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"30844_CR60","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.biopha.2012.12.001","volume":"67","author":"Y. Baran","year":"2013","unstructured":"Baran, Y., Ceylan, C. & Camgoz, A. The roles of macromolecules in imatinib resistance of chronic myeloid leukemia cells by Fourier transform infrared spectroscopy. Biomed. Pharmacother. 67(3), 221\u2013227. https:\/\/doi.org\/10.1016\/j.biopha.2012.12.001 (2013).","journal-title":"Biomed. Pharmacother."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30844-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30844-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30844-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:11:27Z","timestamp":1781622687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30844-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["30844"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-30844-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1214"}}